Kwan Pui San 4
4 · ChemoCentryx, Inc. · Filed Feb 8, 2021
Insider Transaction Report
Form 4
Kwan Pui San
Principal Acctg Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-04$10.86/sh+1,389$15,085→ 4,621 total - Sale
Common Stock
2021-02-04$65.00/sh−3,347$217,555→ 3,232 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-04−1,389→ 15,286 totalExercise: $10.86Exp: 2028-03-05→ Common Stock (1,389 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-02-04−833→ 26,667 totalExercise: $9.04Exp: 2029-11-01→ Common Stock (833 underlying) - Exercise/Conversion
Common Stock
2021-02-04$11.02/sh+1,125$12,398→ 5,746 total - Exercise/Conversion
Common Stock
2021-02-04$9.04/sh+833$7,530→ 6,579 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-04−1,125→ 25,875 totalExercise: $11.02Exp: 2029-03-04→ Common Stock (1,125 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]As of February 4, 2021, and prior to this transaction, the exercised options were fully vested.
- [F3]Not applicable.